Effect on ovarian reserve using various techniques to reduce blood loss for myomectomy

Cover Page


The aim of this study was to establish clinical effectiveness and impact on ovarian reserve different techniques reducing blood loss, after laparoscopic myomectomy (LM). Research included 72 patients who were estimated the level of Anti-Mullerian, FSH and antral follicle counts by ultrasound 12 months after surgery. The study showed that the patients were carried out UAE revealed decreasing the ovarian reserve.

Boris L Tsivyan

Author for correspondence.
North-Western State Medical University named after I.I. Mechnikov
Russian Federation

PhD, professor assistant, Departament of Obstetrics and Gynecology named after S.N. Davidov

Eugenia B Troik

North-Western State Medical University named after I.I. Mechnikov
Russian Federation

MD, Head of the Departament of Obstetrics and Gynecology named after S.N. Davidov

Cristina V Mekoshvili

North-Western State Medical University named after I.I. Mechnikov
Russian Federation

graduate student, Departament of Obstetrics and Gynecology named after S.N. Davidov

Elena V Konstantinova

North-Western State Medical University named after I.I. Mechnikov
Russian Federation

graduate student, Departament of Obstetrics and Gynecology named after S.N. Davidov

  • Buttram VJ, Reiter R. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433-45.
  • Verkauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril. 1992;58:1-15.
  • Mais V, Ajossa S, Guerriero S, et al. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol. 1996;174:654-8.
  • Ecker JL, Foster JT, Friedman AJ. Abdominal hysterectomy or abdominal myomectomy for symptomatic leiomyoma: a comparison of preoperative demography and postoperative morbidity. J Gynecol Surg. 1995;11:11-8.
  • Iverson RE, Chelmow D, Strohbehn K, et al. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol. 1996;88:415-9.
  • Jin C, Hu Y, Chen XC, et al. Laparoscopic versus open myomectomy: a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2009;145:14-21. doi: 10.1016/j.ejogrb.2009.03.009.
  • Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolization to treat uterine myomata. Lancet. 1995;346:671-2.
  • Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the fibroid registry. Obstet Gynecol. 2008;111:22-33. doi: 10.1097/01.AOG.0000296526.71749.c9.
  • Myers ER, Goodwin S, Landow W, et al. Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Obstet Gynecol. 2005;106:44-51. doi: 10.1097/01.AOG.0000165827.66541.dd.
  • Pron G, Bennett J, Common A, et al. The Ontario uterine fibroid embolization trial, part 2: uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril. 2003;79:120-7.
  • Huang JY, Kafy S, Dugas A, et al. Failure of uterine fibroid embolization. Fertil Steril. 2006;85:30-5. doi: 10.1016/j.fertnstert.2005.03.091.
  • Hald K, Kløw NE, Qvigstad E, Istre O. Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Obstet Gynecol. 2007;109: 20-7. doi: 10.1097/01.AOG.0000249602.39339.31.
  • Edwards RD, Moss JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356:360-70. doi: 10.1056/NEJMoa062003.
  • Parker WH. Uterine myomas: management. Fertil Steril. 2007;88:255-71. doi: 10.1016/j.fertnstert.2007.06.044.
  • Tulandi T. Treatment for uterine fibroids – is surgery obsolete? N Engl J Med. 2007;356:411-13. doi: 10.1056/NEJMe068281.
  • McLucas B, Danzer H, Wambach C, Lee C. Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report. Minim Invasive. There Allied Technol. 2013;22(1):45-9. doi: 10.3109/13645706.2012.743918.
  • Seifer DB, Baker VL, Leader B. Age-specific serum anti-müllerian hormone values for 17120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95(2):747-50. doi: 10.1016/j.fertnstert.2010.10.011.
  • Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG. 2005;112(7):956-62. doi: 10.1111/j.1471-0528.2005.00696.x.
  • Hehenkamp WJK, Volkers NA, Broekmans FJM, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22(7):1996-2005. doi: 10.1093/humrep/dem105.
  • Riggs RM, Duran EH, Baker MW, et al. Assessment of ovarian reserve with anti-müllerian hormone: a comparison of the predictive value of anti-müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008;199(2):202-10. doi: 10.1016/j.ajog.2008.05.004.
  • Fanchin R, Schonäuer LM, Righini C, et al. Serum anti-müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18(2):323-7.
  • Testing and interpreting measures of ovarian reserve: a committee opinion. Practice Committee of the American Society for Reproductive medicine. Fertil Steril. 2012;98(6):1407-15. doi: 10.1016/j.fertnstert.2012.09.036.
  • Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol. 2001;12(4):437-42.


Abstract - 139

PDF (Russian) - 153

Copyright (c) 2017 ECO-vector LLC

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.